Same BS as approval was sequestox was a slam dunk last year and still nothing. Same BS as generics are breadcrumbs and suddenly now they are huge. Today is a good example, next to no one is buying this company it’s been slanted the sell side for a year and still is today.
We heard that the SequesTOX wasn't dead after the 1st CRL, and 3 GREEN LIGHTED pathways were all RED LIGHTED! Haven't heard much about bankruptcy I heard it was going to no bid though.
The buyout you have to actually have something someone wants. No one wants anything UN-elite has, well first you'd actually have to have something worth buying WHICH we all KNOW THEY DON'T!
News 
Market Data 
Discover 
